XML 70 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 57,445 $ 62,820
Marketable securities (Notes 3 and 15) 133,044 12,192
Trade and other receivables, net of allowance for credit losses of $223 and $223 as of December 31, 2023 and 2022, respectively 816 519
Inventories (Note 5) 38,868 38,155
Prepaid expenses and other current assets 2,522 9,529
Property, plant and equipment and other assets held for sale, net (Note 7) 0 12,375
Total current assets 232,695 135,590
Other long-term receivables 1,534 1,537
Inventories (Note 5) 1,852 2,465
Operating lease right of use asset 1,219 1,376
Investments (Note 6) 1,356 19,329
Property, plant and equipment, net (Note 7) 26,123 12,662
Mineral properties (Note 7) 119,581 83,539
Restricted cash (Note 8) 17,579 17,449
Total assets 401,939 273,947
Current liabilities    
Accounts payable and accrued liabilities (Note 13) 10,161 6,929
Operating lease liability 199 59
Deposits for assets held for sale 0 6,000
Asset retirement obligation and other liabilities held for sale (Note 8) 0 5,636
Total current liabilities 10,360 18,624
Operating lease liability 1,120 1,319
Asset retirement obligations (Note 8) 10,922 9,595
Deferred revenue 332 0
Total liabilities 22,734 29,538
Equity    
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 162,659,155 and 157,682,531 as of December 31, 2023 and 2022, respectively 733,450 698,493
Accumulated deficit (356,258) (456,120)
Accumulated other comprehensive loss (1,946) (1,946)
Total shareholders' equity 375,246 240,427
Non-controlling interests 3,959 3,982
Total equity 379,205 244,409
Total liabilities and equity 401,939 273,947
Commitments and contingencies (Note 14)